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ABSTRACT
Previous research within the Curran group has demonstrated that ferrocene may be used as an
organometallic constraint to induce the formation of α-helices in short peptides which traditionally
possess undefined conformations. Through strategic placement of lysine residues at the i and i+3
positions within the peptide, such a constraint was accomplished via the crosslinking of the lysine side
chains to ferrocene dicarboxylic acid chloride in solution phase synthesis. The aim of this work was to
develop a method for solid phase peptide synthesis (SPPS) for the synthesis of these ferroceneconstrained helices. In particular, we seek to develop a method in which the nascent peptide can be
cyclized while it is still anchored to the resin. For the synthesis, Fmoc-protected amino acids were utilized
to afford the pentapeptide Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2. For the synthesis, Fmoc-protected
amino acids and Aloc side chain protecting groups were utilized due to the mild conditions under which
they are removed. This allowed the use of a Rink Amide AM resin, which is cleaved under acidic
conditions. In this study it was found that on resin Pd0 catalyzed Aloc removal required very specific
conditions and work up for efficient deprotection. Additionally, Fmoc-protected amino acids were utilized
in an analogous manner to afford the pentapeptide Ac-Lys(Z)-Ala-Val-Lys(Z)-Gly-NH2. The Z-protected
pentapeptide was then removed from the resin, hydrogenated using Pd on C and subsequently cyclized
with 1,1’-ferrocenedicarboxylix acid chloride. Results from on-resin cyclization indicate that a new
approach must be developed in order to accomplish on-resin cyclization. Future work includes the use of
different resins, different protecting groups, and different removal conditions for optimization. In solution
phase, the ferrocene coupling, the data indicates that a peptide dimer with a single ferrocene was formed
due to incomplete Z protecting group removal. Future work in solution phase includes hydrogenation and
cyclization optimization.
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INTRODUCTION
1.1 Protein Chemistry
Within the body, proteins are responsible for a large number of the reactions essential to life. When
describing the particular conformation of a protein, scientists describe protein structure in terms of four
levels of organization: primary, secondary, tertiary, and quaternary. The primary structure of a protein is
simply the linear arrangement of amino acids in a protein. The next level of organization is the secondary
structure, which describes areas of coiling or folding which are formed via hydrogen within the protein
backbone. The tertiary structure is the full three dimensional structure of a given protein. Finally, if
multiple polypeptides make up a given protein complex, the protein is said to have a quaternary structure
which describes the overall shape of the associated subunits.
1.2 Alpha-Helices
Among this hierarchy which describes the organization of a protein, secondary structures, in particular,
are known to play a key role in many important biological activities of proteins. The most common of
these structures, the α-helix, is adopted by 30% of all amino acids in proteins1. The α-helix is a structural
motif involved in an array of vital functions such as protein-DNA interactions2, protein-protein
interactions3, and membrane-bound receptors4. In the ideal α-helix hydrogen bonds form between amide
protons and carbonyl groups of amino acids at the i and i+4 positions5 (see Figure 1.1).

Figure 1.1: An α-helix with (a) Cα labeled, (b) peptide backbone labeled, (c) full structure and hydrogen bonds
shown6.
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In this particular conformation there are 3.6 amino acids per complete turn with Cα-N bond angles (Φ) of 64 ± 7º and Cα-Cβ bond angles (ψ) of -41 ± 7º.7
Due to the biological prevalence of α-helices, it is crucial that researchers have accessible model systems
in order to further probe the intricacies of helix formation and its bioactivity. One of the largest
complications of this need arises from the energetic difficulty which short peptide strands face in forming
well-defined conformations due to their inherent flexibility8. Currently researchers have devised several
reasonably successful methods to induce well defined helices using various conformational
constraints9,10,11 which can be mainly categorized into three major categories: template, covalent and
metal systems.
1.3 Alpha-Helix Prediction
Although researchers have several synthetic methods by which to nucleate alpha-helices, several
statistical models can help predict whether a given peptide will form an alpha-helix. Previous analysis has
shown that certain amino acids exhibit higher frequencies for different secondary structures. In particular,
methionine, alanine, leucine, lysine, and uncharged glutamate have particularly high propensities to form
alpha-helices12. Since the 1960s, researchers have also developed several computational methods to better
predict alpha-helix formation, each of which has a varying degree of accuracy depending on the system
being analyzed. The Chou-Fasman method relies heavily on the frequency of appearance of each amino
acid in alpha-helices and has been shown to be roughly 50-60% accurate at predicting secondary
structures13. A similar method developed by Garnier, Osguthorpe, and Robson (GOR) uses a similar
method that not only takes into account the probability of each amino acid adopting a particular secondary
structure but also the contributions of each amino acid’s neighbors a priori to comparison with proteins of
known structure14. Due to this difference, the GOR method is more sensitive and more accurate (around
65%) than the Chou-Fasman method.
A separate computational approach to predicting secondary structures is to analyze the sequences of
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proteins with known structures and compare them to the desired system. Neural network methods
machines use this approach by grouping amino acid sequences into sets to identify common sequence
motifs of various secondary structures. Similarly based support vector machines use an analogous
processing algorithm to achieve the same goal. These methods are typically greater than 70% accurate13.
In more recent history, many of these prediction systems have been optimized and modified to include a
number of other factors which have also been found to affect secondary structure formation14, including
solvent systems, accessible residue surface area16, and protein structural class17.
1.4 The Template Approach
In template systems, the constraint is placed at one end of the peptide chain, which then serves to nucleate
the formation of an α-helix. Typically, templates consist of semi-flexible cyclic systems containing
multiple carbonyl groups which can participate in hydrogen bonds with the amide protons of the peptide
backbone or within their cyclic framework9. Using this approach, several laboratories have been relatively
successful at synthesizing a number of compounds which tend to adopt α-helical structures.18,19,20 (See
Figure 1.2).

a

b

c
d

Figure 1.2: Various templates for α-helix nucleation (a) Bisproline-based template developed by Gani, (b) Kemp &
Curran’s bisproline-based template, (c) 4-oxo-hexahydroindole-3,6-dicarboxylic acid helix cap developed by
Bartlett & Hutton, (d) Line angle representation of template mechanism of α-helix nucleation.7
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Templates may also be successfully constructed by replacing the hydrogen bond promoting carbonyl
group with sterically hindered covalent systems21 (See Figure 1.3).

Figure 1.3: Satterwat’s hydrazone based hydrogen bond mimic, L = Leu, A = Ala, J = CH2, Z = CH2.7

While the template systems have been shown to successfully induce helix formation, these α-helices tend
to form less than 50% in aqueous solution or were found to be highly length dependent with decreasing
helicity as the peptide strand lengthened10.
1.5 Covalent Constrained Systems
In an alternative system, a covalent constraint is introduced by crosslinking amino acids placed at specific
locations within the peptide. There are a variety of available methods for such systems which vary in both
the positioning of the linkers and the crosslinking reaction type. Successful techniques include constraint
via salt bridges22, lactam formation23,24, disulfide bonds25, thioether formation26, amine formation27, carboncarbon bond formation (via ring olefin closing metathesis (RCM) reaction) 28 and triazole formation via
“click” type reactions29,30.
In a relatively simple approach using salt bridges, α-helix formation is promoted by placing oppositely
charged amino acids, such as glutamic acid and lysine at the i and i+4 positions which form ion pairs at
desired positions, enhancing helix nucleation.22 Via a condensation reaction a lactam may also be formed
to induce helix formation23,24. Additionally, this natural peptide based method has been accomplished by
crosslinking two glutamine residues at the i and i+7 position31 (see Figure 1.4).
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a

b

c

Figure 1.4: (a) Cartoon depicting Glu-Lys salt bridges in stabilized α-helix accomplished by Baldwin22, (b) Glu-Lys
lactam-based constraint system developed by Fairlie, (c) Glutamine based lactam constraint system developed by
Phelan.7

Disulfide bridges, a common structure found in proteins, are also used to form helices from short peptide
strands. This process is accomplished by crosslinking modified amino acids at the i and i+7 positions of
opposite stereochemistry25 via oxidation (see Figure 1.5).

Figure 1.5: Shultz’s α-helix nucleation disulfide constraint25

Similarly, two modified amino acids may be joined using bridging units of different lengths to aid in helix
nucleation depending on the length of the desired cross linking. By using semi-rigid organic compounds
as bridging units, this method has been applied to systems with modified amino acids at the i and i+7, and
i and i+11 positions26,27 (see Figure 1.6).
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a

b

Figure 1.6: Examples of spacer units utilized for α-helix formation, (a) 4-(aminomethyl)phenylacetic acid used by
Taylor, (b) 3,3’-ethyne-1,2-diylbis{6-[(chloroacetyl)amino]benzenesulfonicacid} used as a rigid crosslinker by
Wooley.7

Ring closing metathesis (RCM) has also been applied to the formation of α-helices. In the most successful
of these systems modified amino acids with terminal olefins at the i and i+7 positions with 10 total
methylene spacing groups are crosslinked using Grubbs catalyst28 (see Figure 1.7).

Figure 1.7: Various stapled peptides with different linker lengths and amino acid positions. R and S represent the
stereochemistry of the adjacent amino acid position. The number in parentheses corresponds to the linker length. 28

More recently, with the discovery of “click” type reactions29, on resin crosscoupling has been achieved
using copper catalysts. “Click” mediated systems utilize modified amino acids at the i and i+3 positions
one of which contains an azide and the other which contains an alkyne30,31 (see Figure 1.8).

Figure 1.8: Dawson’s Triazole based tethering system formed through copper-assisted azide-alkyne cycloaddition
(CuAAC).31

Despite the success of many covalent systems, such methodologies often require non-native amino acids
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such as αα-disubstituted amino acids and dehydroaminoacids. Additionally, a number of these reactions
are run with harsh conditions, or expensive cross-coupling reagents such as Pd or Ni based catalysts.
1.6 Metal Constrained Systems
In the metal-ligand mediated system, metal coordinating amino acids such as histidine and cysteine
placed within the peptide chain during synthesis are subsequently coordinated with the desired metal,
constraining the peptide in such a way to induce formation of an α-helix. Metal constrained systems have
been synthesized using a number of modified and native amino acids as well as a range of metals such as
Pd2+, Co2+, Cu2+, Rh, and Cd2+ 33-36 (see Figure 1.9).

a

b

Figure 1.9: (a) Simplified cartoon depiction of metal constrained α-helix, (b) Pd constrained system developed by
Fairlie.7

Although the chemistry involved with metals is often more simple than incorporation of a specific
template, metal-induced α-helices are often very metal specific and typically, as with covalent linking,
require unnatural amino acids9.
Among these methods, metal-ligand constraint, however, does provide several key advantages. In contrast
to template and covalent systems, creation of the α-helix constrained organometallic compound can be
achieved in either one or a very few number of simple steps. In comparison, the synthesis of the template
alone takes many synthetic steps, and then the template must be incorporated into the peptide. RCM
methods contain similar levels of complexity in the synthesis of unnatural amino acids. An
organometallic compound containing a transition metal also provides a simple spectroscopic tool for
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assessing the reactivity and behavior of the target in biochemical and biological settings. Additionally, the
presence of a transition metal can help facilitate X-ray crystal structure elucidation due to its ability to
restrict the peptides conformational fluxionality. Furthermore, the transition metal has the ability to
undergo oxidation and reduction, enabling an investigation of how electronic transitions might affect the
conformation of the complexed peptide.
For the synthesis of peptides, although there are several currently available methods, solid phase peptide
synthesis (SPPS) is the preferred method due to its robustness and efficiency37. For a majority of systems
utilizing the range of previously mentioned constraints, the constraint was introduced after SPPS was
complete and the peptide had been cleaved from the resin. Recently, however, researchers have developed
methodologies for introducing the RCM and click reaction triazole covalent constraints while the peptide
remains on the solid support28,29,30. As previously mentioned, however, both systems require the use of
synthetic amino acids, limiting their potential in fully mimicking biological systems.
Designing an analogous system which would utilize not only the advantages of metal-ligand based
constraints but also the ease of on-resin complexation that would work with only the 20 common amino
acids would be a significant advancement within the field.
1.7 Thesis Work
Previous research within the Curran lab38 has been successful at inducing a 310-helix, a helical structure
that is slightly tighter than that of the α-helix, by crosslinking lysines at the i and i+3 positiong with 1,1'ferrocenedicarboxylic acid. By extending this previous research and redesigning its methodologies to
work with solid phase peptide synthesis (SPPS) this thesis aims to develop and accomplish the synthesis
of compound 1 (see Figure 1.10), an α-helix constrained organometallic.
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Figure 1.10: Target organometallic compound.

First, an attempt will be made to develop a method of synthesis for the compound compatible with SPPS.
Once successful, coupling with ferrocene will be attempted while the peptide remains on its solid support
in an effort to minimize polymerization and possibly improve yields (see Scheme 1.1). In the following
chapters of this thesis is described the progress towards developing a methodology for the on-resin
cyclization of a pentapeptide. Additionally discussed is a second methodology which utilizes SPPS to first
synthesize a pentapeptid, which can then be cleaved and cyclized with ferrocene in solution phase.
Scheme 1.1:

.
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MATERIALS AND METHODS
2.1 Materials & Instrumentation
Commercially available reagents and solvents were used for all purification and synthesis, unless
otherwise noted. 1,1-ferrocenedicarboxylic acid and tetrakis(triphenylphosphine)palladium(0) were
obtained from Strem Chemicals. Methanol, acetic anhydride, trifluoroacetic acid, tetrahydrofuran,
diisopropylethylamine, dimethylformamide, chloroform, and ether were obtained from Fisher Chemicals.
Anisole, oxalyl chloride and 1,8-diazabicycloundec-7-ene (DBU) were purchased from Sigma-Aldrich.
All peptide reagents and peptide coupling reagents (HOBt, HATU) were from Chem-Impex International.
For the ferrocene diacid chloride synthesis, dry CH2Cl2 was obtained from an anhydrous solvent
purification apparatus. Prior to Aloc group removal, the scavenger agent, N-methylaniline was freshly
distilled. Flash chromatography was performed using 60Ǻ pore Ultra Pure Silica Gel from Silicycle. Thin
layer chromatography was performed using EMD chemicals TLC Silica gel 60 F 254 glass backed plates.
All NMR spectra were obtained with a 400 MHz Bruker Avance.
2.2 Preparation of 1,1’-Ferrocenedicarboxylic Acid Chloride39

1

2

Scheme 2.1: Reaction scheme for the preparation of 1,1’-ferrocenedicarboxylic acid chloride

First, 2.011 g (7.34mmol) of ferrocenedicarboxylic acid was reacted with 3.1 mL (4.9 equiv.) of oxalyl
chloride and several drops of pyridine in 35mL of CH2Cl2. A cardboard box and aluminum foil were used
to cover the reaction vessel to protect it from light. The reaction was stirred at room temperature for 12
hours, followed by 6 hours at reflux. The CH2Cl2 was removed by rotary evaporation, and the product
was left to dry overnight under vacuum. The desired product was extracted using approximately 5 x 100
mL of boiling ligroin (≈80ºC) and subsequently decanting the ligroin into a second round bottom. The
ligroin was subsequently removed using rotary evaporation, yielding 1.781g of red crystals (78% yield).
The obtained crystals had a melting point of 91-95ºC, in close agreement with literature values (98ºC 100ºC)39.
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2.3 Investigation of Solvent Effects on Allyloxycarbonyl (Aloc) Group Removal40

Scheme 2.2: Solution phase Aloc removal

First, 1.008g of Fmoc-Lys(Aloc)-OH was massed and transferred into two seperate reaction flasks. The
reaction vessels were then sealed with a rubber septums and put under inert N2 atmosphere. For the first
flask, labeled A, 0.0638g of tetrakis(triphenylphosphine)palladium(0) was dissolved into a solution of
0.1:2:2:1 N-methylaniline:THF:DMF:0.5M HCl, quickly agitated, and added to the reaction flask using a
syringe. For the second reaction flask, labeled B, 0.0638g of (triphenylphosphine)palladium(0) was
dissolved into a solution of 0.1:2:2:1 N-methylaniline:THF:DMSO:0.5M HCl and added to the reaction
flask using a syringe. The reactions were then stirred and monitored by TLC with samples taken every 60
minutes for analysis. A 1:1 MeOH:CHCl3 was used as the eluent. To aid in the analysis, the reaction
mixtures A and B were run in comparison to the unreacted Fmoc-Lys(Aloc)-OH starting material, labeled
U on the TLC plates (Figure 2.1).

Figure 2.1: TLC plates of Aloc removal reaction mixture with an eluent of 1:1 MeOH:CHCl 3

After 20 hours, both reactions were removed from stirring and the solvent solution was evaporated with a
rotary evaporator. The crude product mixtures were then analyzed and compared using 1H NMR (Figures
2.2, 2.3, and 2.4).
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Figure 2.2: 1H NMR of Fmoc-Lys(Aloc) OH in DMSO-d6

Figure 2.3: 1H NMR of crude product of Aloc removal attempted with DMF
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Figure 2.4: 1H NMR of crude product of Aloc removal attempted with DMSO

2.4 Preparation of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2

Scheme 2.3: Solid phase preparation of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2
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First 0.500g (0.365 mequiv) of Fmoc-Gly-Rink amide AM resin (Chem-Impex International) was added
to a solid phase reaction vessel. Approximately 4.5mL (3x the resin volume) of CH2Cl2 was then added to
the vessel and the resin was allowed to swell for 30 minutes with gentle agitation. The CH 2Cl2 was
subsequently drained and the resin was washed with 4.5mL of DMF with gentle agitation for 2 minutes,
followed by draining. The DMF wash was performed 5 times. The Fmoc group was then removed using
1.5mL (1x the resin volume) of a deprotecting solution (1:1:48 DBU:piperidine:DMF). The resin was
washed 5 times with DMF in 2 minute intervals with gentle agitation and draining in between each rinse.
A second round of DMF washes was then performed. To add the next amino acid, 0.826g (5 equiv) of
Fmoc-Lys(Aloc)-OH and 0.682g of HATU (4.9 equiv) were first dissolved in a minimal amount (≈12mL)
of DMF. Immediately prior to adding the peptide solution to the resin, 0.640mL of DIPEA were added to
the peptide solution, the mixture was stirred, and subsequently added to the resin. After 1 hour of gentle
agitation the remaining solution was drained off and the resin was once again washed with DMF as
described above. The deprotection and DMF washes were then repeated. Next, 0.922g (5equiv) of FmocVal-OPfp and 0.253g (5 equiv) of HOBt were dissolved in a minimal amount of DMF and added to the
reaction vessel. After agitation for 1 hour, the solution was then drained and the wash/deprotect/wash
procedure was followed once again. Using this method 0.875g (5equiv) of Fmoc-Ala-OPfp and 0.829g (5
equiv) Fmoc-Lys(Aloc)-OH were then added to the solid phase vessel and reacted. For the activated ester
amino acids derivatives (those with a OPfp group) HOBt was utilized, whereas those with the unactivated
amino acids (those with an OH) were coupled using the combination of HATU and DIPEA. After the
resin was washed 5 times with DMF, 5 washes of deprotection solution, and 5 times with DMF, 0.345 mL
(10 equiv.) of acetic anhydride in a minimal amount of DMF was added to the resin and allowed to react
for 1 hour with gentle agitation.
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2.5 Solution phase Ferrocene Coupling with Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2

Scheme 2.4: Solution phase crosslinking of pentapeptide with ferrocene

In addition to the attempted on-resin coupling, a solution phase methodology for crosslinking the
synthesized pentapeptide with ferrocene was also attempted. First 0.0946 g (1 equiv) of dried resin was
transferred to a second reaction vessel. The peptide was cleaved from the resin via the addition of 3mL
(3x the resin volume) of 95:2.5:2.5 TFA:anisole:H2O v/v solution with gentle agitation for 3 hours. The
solution within the reaction vessel was then drained into a round bottom flask. The resin was
subsequently washed 2 times with 3mL of TFA and combined with the previous removal solution
fractions. After the solvent was evaporated using a high vacuum rotary evaporator, the resulting product
was then triturated with ether several times to remove impurities. The 1H NMR of the product was
consistent with the desired pentapeptide. COSY and 1H NMR were utilized to make peak assignments for
each hydrogen found within the product (Figure 2.5, Table 2.1, Figure 2.6, Table 2.2).
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Figure 2.5: 1H NMR of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 in DMSO-d6.
Table 2.1: Peak Data for 1H NMR of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 in DMSO-d6.
δ (ppm)

Integral

splitting

8.09

1H

m

Ala-NH

8

1H

m

Gly-NH

7.97

1H

m

J-Coupling

Identity

Lys-NH

7.75

1H

d

3

7.69

1H

d

3

7.15

1H

m

Lys-Amine

7.07

1H

m

Lys-Amine

6.96

2H

s

Terminal Amide

5.89

2H

o

5.25
5.15

2H
2H

J: 7.58 Hz
J: 8.37 Hz

Lys-NH
Val-NH

Aloc-CH

dd

2

3

Aloc Terminal CH

dd

2

3

Aloc Terminal CH

J: 17.52 Hz, J: 1.78 Hz
J: 10.48 Hz, J: 1.57 Hz
3

4.44

4H

d

4.3

1H

m

J: 5.45 Hz

Aloc-CH2
Ala-CαH

4.2

1H

m

Lys-CαH

4.15

1H

m

Lys-CαH

4.11

1H

m

Val-CαH

3.60

2H

m

Gly-CαH
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2.93

2H

m

Lys-N-CH2

2.93

2H

m

Lys-N-CH2

1.97

1H

m

Val-CβH

1.83

3H

s

Ac-CH3

1.69-1.21

13 H

m

Lys-CH2

1.19

3H

m

0.82

6H

d

Ala-CH3
3

J: 10.90 Hz

Val-CH3

Figure 2.6: 2D COSY NMR of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 in DMSO-d6.
Table 2.2: Cross Coupling Peaks for COSY of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 in DMSO-d6.
Cross Peak Coupling Hydrogens
Ala-NH (8.09ppm) with Ala-Cα-H (4.30ppm)
Gly-NH (8.00ppm) with Gly-Cα-H (3.60ppm)
Lys-NH (7.97ppm) with Lys-Cα-H (4.20ppm)
Lys-NH (7.75ppm) with Lys-Cα-H (4.15ppm)
Val-NH (7.69ppm) with Val-Cα-H (4.11ppm)
Lys-Amine (7.15ppm) with Lys-CH2-N (2.93ppm)
Lys-Amine (7.07ppm) with Lys-CH2-N (2.93ppm)
Aloc-CH (5.89ppm) with Aloc-CH2 (4.44ppm)
Aloc-CH (5.89ppm) with Aloc Terminal CH (5.25ppm)
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Aloc-CH (5.89ppm) with Aloc Terminal CH (5.15ppm)
Aloc Terminal CH (5.25ppm) with Aloc-CH2 (4.44ppm)
Aloc Terminal CH (5.15ppm) with Aloc-CH2 (4.44ppm)
Ala-Cα-H (4.30ppm) with Ala-CH3 (1.19ppm)
Lys-Cα-H (4.20ppm) with Lys-CH2 (1.69-1.21ppm)
Lys-Cα-H (4.15ppm) with Lys-CH2 (1.69-1.21ppm)
Val-Cα-H (4.11ppm) with Val-Cβ-H (1.97ppm)
Lys-CH2-N (2.93ppm) with Lys-CH2 (1.69-1.21ppm)
Val-Cβ-H (1.97ppm) with Val-CH3 (1.69-1.21ppm)
Lys-CH2 (1.69-1.21ppm) with Lys-CH2 (1.69-1.21ppm)

The allyloxycarbonyl (Aloc) groups on the two lysine residues at i and i+3 positions within the peptide
were then removed by reaction with a solution of 2:2:1:0.1 DMF:THF:0.5M HCl: freshly distilled Nmethylaniline v/v solution (≈ 5.1mL/100mg resin). In this reaction Pd(PPh3)4 was used as a catalyst with a
0.25 equivalent load (0.01995g). To protect the catalyst, the reaction was run under inert N2 atmosphere.
The reaction was left stirring for 24 hours and the solvent was subsequently removed under high vacuum.
Upon heating to remove the solvent, the solution transitioned from a light yellow color to a dark purple.
The color change was attributed to the poisoning of the Pd catalyst.
Ferrocene crosslinking was then attempted with the crude product. The unpurified mixture was first
dissolved in approximately 12.5mL of DMF. A solution of 0.0215g (1 equiv) of 1,1’ferrocenedicarboxylic acid chloride in 5 mL of DMF was first added to a stirring solution of the crude
unprotected peptide followed by the addition of 115µL of DIPEA. The coupling reaction was conducted
under inert N2 atmosphere. After 24 hours, the solvent was then removed using a high vacuum rotary
evaporator. Due to the known impurity of the product, no accurate mass of the desired product could be
obtained, but the mass of the crude sample was approximately 150mg.
The 1H NMR of the product indicates that complete removal of the Aloc group was incomplete (Figure
2.7).
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Figure 2.7: 1H NMR of solution phase cyclization attempt with unpurified peptide

Based on integration values, about 50% of the Aloc groups were removed. Despite this, the 1H NMR also
indicates the presence of peaks in the 4.5-5ppm region, characteristic of ferrocene being present, so flash
chromatography was attempted. Flash chromatography, with an eluent of 10:1 chloroform:methanol, was
used to separate the product mixture. The crude product was then dissolved in a minimal amount of HFIP
and added to the packed 1.5cm column. A total of 36 2mL fractions from the column were collected and
analyzed using thin layer chromatography (TLC). Due to the difficulty of separation to obtain a pure
crosslinked product, purification was halted.
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2.6 Preparation of Ac-Lys(Z)-Ala-Val-Lys(Z)-Gly-NH2

Scheme 2.5: Solid phase preparation of Ac-Lys(Z)-Ala-Val-Lys(Z)-Gly-NH2

First 0.1028g (0.07504 mequiv) of Fmoc-Gly-Rink amide AM resin (Chem-Impex International) was
added to a solid phase reaction vessel. Approximately 3.0mL (3x the resin volume) of CH 2Cl2 was then
added to the vessel and the resin was allowed to swell for 30 minutes with gentle agitation. The CH 2Cl2
was subsequently drained and the resin was washed with 3mL of DMF with gentle agitation for 2
minutes, followed by draining. The DMF wash was performed 5 times. The Fmoc group was then
removed using a 1.0mL (1x the resin volume) a deprotecting solution (1:1:48 DBU:piperidine:DMF). The
resin was washed 5 times with DMF in 2 minute intervals with gentle agitation and draining in between
each rinse. A second round of DMF washes was then performed. To add the next amino acid, 0.1920g (5
equiv) of Fmoc-Lys(Z)-OH and 0.1399 of HATU (4.9 equiv) were first dissolved in a minimal amount
(≈4mL) of DMF. Immediately prior to adding the peptide solution to the resin, 0.130mL (10 equiv) of
DIPEA were added to the peptide solution, the mixture was stirred, and subsequently added to the resin.
After 1 hour of gentle agitation the remaining solution was drained off and the resin was once again
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washed with DMF as described above. The deprotection and DMF washes were then repeated. Next,
0.1911g (5equiv) of Fmoc-Val-OPfp and 0.0517g (5 equiv) of HOBt were dissolved in a minimal amount
of DMF and added to the reaction vessel. After agitation for 1 hour, the solution was then drained and the
wash/deprotect/wash procedure was followed once again. Using this method 0.1808g (5equiv) of FmocAla-OPfp and 0.1691g (5 equiv) Fmoc-Lys(Z)-OH were then added to the solid phase vessel and reacted.
For the activated amino acids (those with a OPfp group) HOBt was utilized, whereas with the unactivated
amino acids (those with an OH) were coupled using the combination of HATU and DIPEA. After the
resin was washed 5 times with DMF, 5 washes of deprotection solution, and 5 times with DMF, 0.345 mL
(10 equiv.) of acetic anhydride in a minimal amount of DMF (≈1.5mL) was added to the resin and
allowing to react for 1 hour with gentle agitation. After draining and washing with DMF (5×3mL) The
resin was subsequently dried under N2. The peptide was then cleaved from the resin using 3mL of a
removal solution of 95:2.5:2.5 TFA:anisole:H2O v/v solution with gentle agitation for 3 hours.
Subsequently, the resin was washed with 2mL of TFA for 2 minutes and all of the filtrates were collected
in a single round bottom flask. The solvent was then evaporated off yielding a crude mass of 0.64mg. The
1

H NMR of the product was consistent with the desired pentapeptide. COSY and 1H NMR were utilized

to make peak assignments for each hydrogen found within the product (Figure 2.8, Table 2.3, Figure 2.9,
Table 2.4).

Figure 2.8: 1H NMR of Ac-Lys(Z)-Ala-Val-Lys(Z)-Gly-NH2 in DMSO-d6
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Table 2.3: Peak data for the 1H NMR of Ac-Lys(Z)-Ala-Val-Lys(Z)-Gly-NH2 in DMSO-d6
δ (ppm)

Integral

Splitting

8.11

1H

m

Ala-NH

8.05

1H

m

Gly-NH

8

1H

m

7.77

1H

d

3

Lys-NH

3

Val-NH

J-Coupling

Identity

Lys-NH
J: 7.89 Hz

7.71

1H

d

J: 8.97 Hz

7.34

10 H

m

Cbz-Benzyl

7.23

1H

m

Lys-Amine

7.11

1H

m

Lys-Amine

6.89

2H

s

Terminal Amide

5

4H

s

Cbz-CH2

4.3

1H

m

Ala-CαH

4.2

1H

m

Lys-CαH

4.15

1H

m

Lys-CαH

4.11

1H

m

Val-CαH

3.67

2H

m

Gly-CαH

2.95

2H

m

Lys-N-CH2

2.95

2H

m

Lys-N-CH2

1.97

1H

m

Val-CβH

1.83

3H

s

Ac-CH3

1.69-1.21

13 H

m

Lys-CH2

1.19

3H

m

0.82

6H

d

Ala-CH3
3

J: 10.90 Hz

Val-CH3
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Figure 2.9: 2D COSY NMR of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 in DMSO-d6.

Table 2.4:Cross Coupling Peak data for the 1H NMR of Ac-Lys(Z)-Ala-Val-Lys(Z)-Gly-NH2 in DMSO-d6
Cross Peak Coupling Hydrogens
Ala-NH (8.11ppm) with Ala-Cα-H (4.30ppm)
Gly-NH (8.05ppm) with Gly-Cα-H (3.67ppm)
Lys-NH (8.00ppm) with Lys-Cα-H (4.20ppm)
Lys-NH (7.77ppm) with Lys-Cα-H (4.15ppm)
Val-NH (7.71ppm) with Val-Cα-H (4.11ppm)
Cbz-Benzyl (7.34ppm) with Cbz-Benzyl (7.34ppm)
Lys-Amine (7.23ppm) with Lys-CH2-N (2.95ppm)
Lys-Amine (7.11ppm) with Lys-CH2-N (2.95ppm)
Ala-Cα-H (4.30ppm) with Ala-CH3 (1.19ppm)
Lys-Cα-H (4.20ppm) with Lys-CH2 (1.69-1.21ppm)
Lys-Cα-H (4.15ppm) with Lys-CH2 (1.69-1.21ppm)
Val-Cα-H (4.11ppm) with Val-Cβ-H (1.97ppm)
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Lys-CH2-N (2.95ppm) with Lys-CH2 (1.69-1.21ppm)
Val-Cβ-H (1.97ppm) with Val-CH3 (1.69-1.21ppm)
Lys-CH2 (1.69-1.21ppm) with Lys-CH2 (1.69-1.21ppm)

2.7 Solution Phase synthesis of Ferrocene Crosslinked Ac-Lys-Ala-Val-Lys-Gly-NH2

Scheme 2.6: Solution phase cyclization using Z protected peptide

To begin, all of the resin cleaved pentapeptide, Ac-Lys(Z)-Ala-Val-Lys(Z)-Gly-NH2, product from the
previous step (≈50mg) was dissolved in 12.5mL of DMF and transferred to a Parr hydrogenation flask.
Under a stream of running N2, 0.0267g of 5% Pd on C was then added to the solution. The flask was then
placed in a Parr hydrogenation apparatus and hydrogenated for 24 hours at 40psi. The catalyst was
subsequently removed via vacuum filtration through celite into a three neck flask. The solution was then
brought to a total volume of 70mL of DMF. An addition funnel was added and the system was put under
N2. 0.191g of ferrocene dicarboxylic acid chloride was dissolved in 10mL of DMF and added to the
addition funnel. To the solution was then added 0.250mL of DIPEA via a syringe. The ferrocene
dicarboxylic acid chloride solution was then added to the reaction flask over the course of an hour and the
reaction was allowed to stir for 24 hours. The bronze colored solution was then transferred to a second
flask and the DMF was evaporated using a rotary evaporator. The crude mixture was then washed with
MeOH and the MeOH was decanted into a second round bottom flask. The MeOH was then evaporated to
yield a crude black film with a mass of 50mg. The 1H NMR indicates that there is ferrocene in the product
mixture (Figure 2.10).
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Figure 2.10: Crude solution phase ferrocene cyclized product using Z protected peptide

Flash chromatography was attempted on the crude mixture, but after evaporation, the obtained black film
was no longer soluble in MeOH. Due to time constraints, flash chromatography could not be fully
completed, although intial TLC analysis indicated that pure MeOH was not a sufficient eluent and that
acetic acid must be added for adequate separation. It is also noted that upon dissolution in DMF, the black
film had a redish tint, indicative of the presence of ferrocene.
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2.8 Preparation of Ferrocene Crosslinked Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 On-resin

Scheme 2.7: On resin preparation of Ferrocene crosslinked Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2

To begin 0.1019g (0.07439 mequiv) of Fmoc-Gly-Rink amide AM resin (Chem-Impex International) was
added to a solid phase reaction vessel. Approximately 3.0mL (3x the resin volume) of CH 2Cl2 was then
added to the vessel and the resin was allowed to swell for 30 minutes with gentle agitation. The CH2Cl2
was subsequently drained and the resin was washed with 3.0mL of DMF with gentle agitation for 2
minutes, followed by draining. The DMF wash was performed 5 times. The Fmoc group was then
removed using 1.0mL of a deprotecting solution (1:1:48 DBU:piperidine:DMF). The resin was washed 5
times with DMF in 2 minute intervals with gentle agitation and draining in between each rinse. A second
round of DMF washes was then performed. To add the next amino acid, 0.1695g (5 equiv) of FmocLys(Aloc)-OH and 0.1383g of HATU (4.9 equiv) were first dissolved in a minimal amount (≈4mL) of
DMF. Immediately prior to adding the peptide solution to the resin, 0.1296mL of DIPEA were added to
the peptide solution, the mixture was stirred, and subsequently added to the resin. After 1 hour of gentle
agitation the remaining solution was drained off and the resin was once again washed with DMF as
described above. The deprotection and DMF washes were then repeated. Next, 0.1923g (5equiv) of
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Fmoc-Val-OPfp and 0.0514g (5 equiv) of HOBt were dissolved in a minimal amount of DMF (≈4mL)
and added to the reaction vessel. After agitation for 1 hour, the solution was then drained and the
wash/deprotect/wash procedure was followed once again. Using this method 0.1529g (5equiv) of FmocAla-OPfp and 0.1691g (5 equiv) Fmoc-Lys(Aloc)-OH were then added to the solid phase vessel and
reacted. For the activated ester amino acid derivatives (those with a OPfp group) HOBt was utilized,
whereas with the unactivated amino acids (those with an OH) were coupled using the combination of
HATU and DIPEA. After the resin was washed 5 times with DMF, 5 washes of deprotection solution, and
5 times with DMF, 0.070 mL (10 equiv.) of acetic anhydride in a minimal amount of DMF was added to
the resin and allowing to react for 1 hour with gentle agitation. The resin was then dried under N2 and
subsequently swelled for 30 minutes using CH2Cl2. After draining off the CH2Cl2, the reaction vessel was
covered

with

aluminum

foil

and

flushed

with

N2.

Next,

0.0872g

(1

equiv)

of

tris(triphenylphosphine)palladium(0) and 0.1055g (10 equiv) of dimedone were then dissolved in a
solution of dry, degassed CH2Cl2 and THF (0.5mL:0.5mL). Using a syringe this solution was then added
to the reaction vessel and agitated using a shaker for 6 hours. The solution was then drained and the resin
was washed with 0.5% v/v DIPEA in DMF (5×10mL), 0.5% w/v dimethylddithiocarbamic acid soldium
salt solution (10×10mL), dry CH2Cl2 (5×10mL) and dry diethylether (5×5mL). The resin was then dried
under vacuum for several minutes. In order to crosslink the deprotected peptide, after flushing the
reaction vessel with N2, 0.0261g (1.13equiv) of 1,1’-ferrocene dicarboxylic acid chloride in 1mL of DMF
was added to the resin in addition to 0.130mL of DIPEA and the reaction vessel was shaken. After 96
hours, the reaction vessel was drained and subsequently washed with DMF (5×4mL) in two minute
intervals. In order to acylate any unreacted free amines, 0.070mL (10 equiv) of acetic anhydride was
dissolved in 1mL of DMF and subsequently added to the resin. After 1 hour of shaking, the solution was
drained and washed with DMF once again. The resin was subsequently dried under N2 and the peptide
was cleaved from the resin using a removal solution of 95:2.5:2.5 TFA:anisole:H2O v/v solution with
gentle agitation for 3 hours. The resin was then finally washed with two volumes of TFA for 2 minutes
and all of the filtrates were collected in a single round bottom flask. The solvent was then evaporated off
using a rotary evaporator yielding a crude mass of 0.1052g. The 1H NMR of the crude product does not
contain any substantial peaks within the 4.5-5.0ppm region, characteristic of ferrocene Cp rings (Figure
2.11). Due to absence of ferrocene peaks, no purification attempt was made of the crude product.
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Figure 2.11: Crude on resin ferrocene cyclization with Aloc protected peptide
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RESULTS AND DISCUSSION
The goal of this study was to successfully synthesize a pentapeptide with lysine residues at the i and i+3
positions which could be crosslinked with 1,1’-ferrocenedicarboxylic acid chloride while still on-resin.
For the on resin synthesis, Fmoc based solid phase peptide synthesis (SPPS) was utilized. SPPS is
advantageous due to the high purity and efficiency it affords in comparison to solution phase peptide
synthesis. In SPPS, the amino acid is immobilized on the surface of an insoluble polymer This
methodology allows for sequential addition of amino acids to the N-terminus of the immobilized amino
acid, enabling precise control of peptide assembly. During synthesis, the terminal amino acid is
deprotected and the next amino acid is added. This process is repeated until the desired peptide is
synthesized. Subsequently, the peptide chain is cleaved from the resin and desired product is obtained.
Currently, there are two major protecting groups compatible with SPPS: Fmoc and Boc. Fmoc based
SPPS was chosen over Boc based systems due to the milder reaction conditions and lack of special
equipment required for the synthesis. Additionally, the highly acidic conditions for Boc removal would
lead to premature cleavage of the peptide from the resin compatible with the possible on resin cyclization.
To begin, 1,1’-ferrocenedicarboxylic acid chloride was prepared using previously published syntheses1
(Scheme 3.1).
3.1 Preparation of 1,1’-Ferrocenedicarboxylic Acid Chloride1

1

2

Scheme 3.1: Reaction scheme for the preparation of 1,1’-ferrocenedicarboxylic acid chloride

This methodology requires that the reaction be kept in the dark for 12 hours. Aluminum foil covering the
flask was found to be sufficient. To limit exposure to water vapor, the reaction was also run with a rubber
septum pierced with a syringe tip for ventilation. In order to confirm the product, melting point analysis
was performed on the resulting red/crimson solid. The melting point was found to be 87°C-95°C, slightly
lower than the reported literature value of 98°C-100°C. It is assumed that trace impurities are responsible
for the slightly lower experimental value determined. The main source of impurities for the formed diacid
chloride is hydrolysis to the starting dicarboxylic acid product, which has a melting point of 210°C215°C. Given that the experimental value was lower than reported, it was assumed that this impurity was
present only in trace amounts. In order to prolong the life of the 1,1’-ferrocenedicarboxylic acid chloride
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product, the solid was kept under either N2 or vacuum in a refrigerator. Additionally, prior to each use, the
crude product was washed redissolved with dry ethyl ether, filtered to remove impurities, and the solvent
was evaporated to ensure purity as the diacid chloride is soluble in ether, whereas, the diacid is not. The
experimental yield of 78% was comparable to the published results, validating this as an effective
methodology for the preparation of 1,1’-ferrocenedicarboxylic acid chloride.
3.2 Preparation of Ferrocene Crosslinked Ac-Lys-Ala-Val-Lys-Gly-NH2
In the first attempt, the entire synthesis of Ac-Lys-Ala-Val-Lys-Gly-NH2 cyclized on resin with ferrocene
was carried out in its entirety (Scheme 3.2)

Scheme 3.2: On-resin cyclization of Ac-Lys-Ala-Val-Lys-Gly-NH2

To begin, the pentapeptide Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 was prepared on resin. This was
accomplished using Fmoc solid phase peptide synthesis (SPPS).
For the synthesis, Fmoc-protected amino acids and Aloc-protected lysines residues were utilized due to
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the mild conditions under which they are removed. This allowed for the use of a Rink Amide AM resin,
which is cleaved under acidic conditions. In order to place lysine residues at the i and i+3 positions, only
a tetrapeptide is required. The only commercially available lysine bound Rink Amide AM resin, however,
has a Boc side chain protecting group. Boc groups are easily cleaved under the same conditions as the
Rink Amide AM resin, making it unusable for our purposes. Due to the fact that the lysine residue could
not be placed on the C-terminus, a glycine bound Rink Amide AM resin was utilized. A glycine residue
was chosen due to its minimal steric bulk. Therefore a pentapeptide, rather than a tetrapeptide was
synthesized. In addition all amino acids were used in their carboxylic acid or OPfp ester forms and
activated using coupling reagents during synthesis. In particular the use of OSu derivatives was avoided
due to previous studies which have shown that even in the presence of HOBt, reactions with OSu esters
tend to be slow and form unwanted side products41.
The first steps of SPPS are relatively simple. In order for efficient reaction, the dried resin must first be
swollen to allow adequate access to the resin bound amino acid. This is done by adding the dried resin to
the solid phase vessel and swelling with CH2Cl2 for 30 minutes with agitation. The Fmoc protecting
group is then removed via a series of washes, followed by addition of the next amino acid dissolved in a
minimal amount of DMF. The reaction was then gently agitated by shaking for one hour. The resin was
then washed and the Fmoc group was once again removed, followed by subsequent addition of the next
amino acid. This process could then be repeated as many times as necessary to complete synthesis of the
desired peptide. In this manner, alloxycarbonyl protected lysine, valine, alanine, and alloxycarbonyl
protected lysine were added to form the desired pentapeptide Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2.
The lysine derivatives were purchased in their carboxylic acid form, and as such required activation for
effective addition. This was accomplished using in situ generation of the activated ester derivative by
reaction with HATU and DIPEA (Scheme 3.3).

Scheme 3.3: In situ activation of carboxylic acid amino acids with HATU

All other amino acids were used as OPfp activated esters. Although not required, HOBt was used to
activate these amino acids in situ in order to increase yields. The generation of the activated ester is very
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similar to that of HATU (Scheme 3.4).

Scheme 3.4: In situ activation of the OPfp amino acids

Finally, the Fmoc group was removed from the terminal residue and an acetyl group was added via the
addition of acetic anhydride in DMF to the resin, in the same manner as the previous amino acids. It is
important to note that these groups were removed due to the lability of Fmoc protecting groups under
basic conditions and their tendency to make reaction mixtures more difficult to separate.
Aloc group removal was then attempted. Prior to reaction, the tetrakistriphenylphosphinepalladium(0)
catalyst was washed with methanol to remove impurities. The solution was then decanted and discarded
while the remaining solid was placed under vacuum to remove any remain MeOH. The reaction vessel
was then drained and purged with flowing N2. Tetrakistriphenylphosphinepalladium(0), dissolved in 5mL
of 2:2:1:0.5 solution of DMF:THF:0.5M HCl: N-methylaniline was then added to the reaction flask. The
resin was subsequently washed and repurged with N2. Cyclization was then attempted via the addition of
1,1’-ferrocenedicarboxylic acid chloride and DIPEA as a base. In order to gauge and potentially quantify
the amount of free amine present (if any) in the resulting product, the resin was treated with acetic
anhydride in DMF for 1 hour prior to resin cleavage. In order to remove the cyclized peptide from the
solid support, the resin was treated with a removal solution and agitated by shaking for 3 hours. The
resulting solution was then drained into a flask and freeze dried overnight. The pale pink solid was then
characterized via 1D 1H NMR, 2D 1H NMR COSY and ROESY, as well as circular dichroism. Initial 1H
NMR data indicated that the Aloc groups had not been successfully removed (Figure 3.1).
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Figure 3.1: Crude product from on-resin Cyclization of Ac-Lys-Ala-Val-Lys-Gly-NH2 with Ferrocene
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3.3 Solid Phase Preparation of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2

Scheme 3.4: Solid phase preparation of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2

As stated, during the characterization of the on-resin cyclization product, the reaction was also attemped
off-resin. First, the dried resin was added to the solid phase vessel and the resin was swelled with CH 2Cl2
for 30 minutes with agitation. The Fmoc protecting group was then removed via a series of washes,
followed by addition of the next amino acid dissolved in a minimal amount of DMF. The reaction was
then gently agitated by shaking for one hour. The resin was then washed and the Fmoc group was once
again removed, followed by subsequent addition of the next amino acid. This process could then be
repeated as many times as necessary to complete synthesis of the desired peptide. In this manner,
alloxycarbonyl protected lysine, valine, alanine, and alloxycarbonyl protected lysine were added to form
the desired pentapeptide Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2. In order to remove the peptide from
the solid support, the resin was treated with a removal solution and agitated by shaking for 3 hours. After
rotary evaporation, the resulting peptide was triturated with diethyl ether to yield a beige solid.
This solid was characterized by 1D 1H NMR, which indicated that the desired product was present with
little to no impurities. To confirm the peak assignments a 2D 1H COSY, which exhibits crosspeaks for
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hydrogens one bond apart, was obtained. The exhibited cross peaks were consistent with the initial
assignments from 1D 1H NMR. An MS of the resulting product was not obtained because the instrument
was not working at the time, but based on consistency of the 1D and 2D 1H NMR data, it was assumed
that the peptide was successfully synthesized.
3.4 Solution Phase Aloc Deprotection of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2
Using the off-resin pentapeptide, a solution phase removal of the protecting Aloc groups was attempted.
The previously prepared pentapeptide was first placed under an inert atmosphere of N2 in a round bottom
flask. To the flask was then added tetrakistriphenylphospinepalladium(0) (purified as previously
discussed) in 5mL of a 2:2:1 solution of DMF:THF:0.5M HCl with N-methylaniline as the organic
scavenger. After addition of the removal solution via a syringe, the reaction was monitored via TLC.
Samples of the product mixture were then taken every 45 minutes for 7 hours. Within this time period, no
noticeable difference in the Rf was observed, with all plates exhibiting 3 major spots with Rf values of
0.96, 0.91, and 0 respectively.

Figure 3.2: TLC of Aloc removal reaction mixture run with 1:1 CHCl 3:MeOH mixture.

The reaction was run overnight and a final sample was analyzed via TLC, but no measurable differences
in Rf values were observed. A 1D 1H NMR was then taken of the crude product mixture to determine the
efficiency of the Aloc removal.
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Figure 3.3: 1H NMR of crude solution phase Aloc removal product in DMSO-d6

Within the 1H NMR spectrum, the Aloc peaks can still be observed, indicating that once again, the Aloc
group removal was incomplete. Using the integration values of the Aloc peaks, the efficiency of the
reaction was then be estimated. The complete peptide contains two Aloc groups, meaning that the
integration values should be 2:2:2:4 for the assigned peaks in Figure 3.3. The experimental values,
however, are half of the expected values, indicating that only about ½ of the Aloc groups are being
removed from the peptide. There are several factors which could have contributed to the lack of
success/efficiency. Due to the sensitivity of the Pd(0) catalyst, it was hypothesized that the catalyst
precursor was either no longer active or that the active catalyst was being poisoned during the reaction by
impurities in the N-methylaniline scavenger. In order to avoid this complication, the reaction was then run
in the same manner but using freshly distilled N-methylaniline. It is of note that the freshly distilled Nmethylaniline was significantly paler after distillation and noticeably more viscous. Once again, TLC was
used to monitor the reaction, but no observable differences in Rf values were observed across the reaction
duration. The observed spots had Rf values of 0.95, 0.88, 0.77, and 0 with an eluent of 1:1 CHCl3:MeOH
(Figure 3.4).
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Figure 3.4: TLC plate of off-resin solution phase Aloc removal crude reaction mixture
Given the fast elution of two major compounds on the TLC plates, it is assumed that the lack of difference
in the collected reaction plates may be due to the use of too polar of an eluent. The solvent was then
evaporated using a rotary evaporator and the resulting product was characterized via 1D 1H NMR (Figure
3.5).

Figure 3.5: 1H NMR of crude product mixture of Aloc removal attempted with distilled N-methylaniline

Within the 1H NMR, the Aloc peaks have almost entirely disappeared, indicating that removal was mostly
successful. Once again, using the integration values, the removal percentage can be estimated. Using the
Val CH3 groups as a standard, the reaction was calculated to have removed approximately 75% of the
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Aloc protecting groups. With the relative success of the Aloc removal, it was assumed that impurities in
the undistilled N-methylaniline were mostly responsible for poisoning the catalyst in previous attempts.
Due to the reactivity of the free amines in the unprotected pentapeptide, synthesis was continued without
purification of the crude product mixture.
3.5 Solution Phase Cyclization of Ac-Lys-Ala-Val-Lys-Gly-NH2
With a majority of the Aloc protecting groups successfully removed, cyclization was attempted in
solution phase (Scheme 3.5).

Scheme 3.5: Solution Phase Cyclization of Ac-Lys-Ala-Val-Lys-Gly-NH2

Before the reaction could be conducted, the small volume of DMSO-d6 used as the NMR solvent was
evaporated off. During the process, it was observed that the product mixture turned from yellow to purple
upon heating. It is believed that the observed color change is mostly due to degradation of the Pd(0)
catalyst. For the synthesis, the crude product mixture was first placed under an inert N 2 gas atmosphere.
1,1’-ferrocenedicarboxylic acid chloride, dissolved in DMF and an excess of DIPEA were then added via
a syringe and the reaction mixture was stirred. The cyclization was allowed to run for 94 hours. The
solvent was then evaporated using a rotary evaporator and a 1D 1H NMR of the crude product mixture
was taken.
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Figure 3.6: 1H NMR of crude solution phase cyclization product

Having not previously removed the Pd(0) catalyst, there were a large number of impurities present in the
crude mixture. In addition, the 1H NMR shows that the Aloc protected impurities are also present.
Although the NMR displays several promising peaks, full characterization of the products would require
1

H NMR data of a higher resolution. Purification by flash chromatography was then attempted using a

10:1 eluent of chloroform:methanol. The crude product was first dissolved in a minimal amount of
hexafluoropropanol and added to a packed column. The fractions were then compared via TLC.

Figure 3.7: TLC analysis of FC fractions 1-8 of solution phase cyclization of pentapeptide

As shown by both TLC and 1H NMR analysis, little separation was accomplished using this method. To
confirm, fraction 5, which contained several spots which appeared orange, was isolated and an 1H NMR
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was recorded. The 1H NMR spectrum, however, did not provide sufficient resolution to confirm the
product. The spots shown in Figure 3.7 which remained on the origin, were purple, and therefore, it was
assumed that they were primarily Pd catalyst. Other fractions were not isolated due to the prevalence of
the palladium catalysts throughout the column, which after loading, was entirely purple in color due to the
lack of separation. It is believed that most of the crude mixture, which was insoluble in most organic
solvents, preferentially stayed dissolved in the HFIP. As an extremely polar molecule, HFIP moves fairly
quickly through the column, and as a result, most of the product ran too quickly, resulting in minimal
separation. Given that the product mixture had so many impurities, purification techniques were halted.
Instead, having proven successful Aloc group removal using freshly distilled N-methylaniline, the onresin cyclization was once again reattempted.
3.6 On-resin cyclization of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2

Scheme 3.6: On-resin cyclization of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 with distilled N-methylaniline

Having successfully removed a majority of the Aloc groups in a solution phase reaction with freshly
distilled N-methylaniline, the on-resin deprotection and cyclization of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)Gly-NH2 was then reattempted. SPPS should also make the isolation of the final product more efficient.
First, the pentapeptide, Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2, was prepared using SPPS, as
previously

described.

To

the

resin,

under

inert

N2

atmosphere,

was

then

added

tetrakistriphenylphosphinepalladium(0) (purified as previously discussed) dissolved in 5mL of a 2:2:1
solution of DMF:THF:0.5M HCl with freshly distilled N-methylaniline. The reaction was then agitated
for 13 hours under flowing N2. Upon returning to the laboratory, it was noted that all of the solvent had
evaporated in the elapsed time. As a result, 5mL of the reaction solution were then added once again and
the reaction was agitated for an additional 13 hours without flowing N2. The resin was then washed and
repurged with N2. A solution of 1,1’-ferrocenedicarboxylic acid chloride in DMF was then added to the
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resin and the reaction mixture was agitated for 74 hours. The resin was then washed and treated with
acetic anhydride in DMF. The peptide was then removed from the resin and the solvent was evaporated.
1D 1H NMR and 2D 1H COSY spectra were then taken for the crude product.

Figure 3.8: On resin cyclization attempt with distilled N-methylaniline

Similar to the solution phase deprotection, based on integration values, the Aloc deprotection step was
found to only be about 75% effective. Before full synthesis could be carried out again, it was decided that
a more effective method must first be developed for the peptide deprotection in order to maximize
product purity and yields.
3.7 Solvent effects on Aloc deprotection efficiencies
It is widely known that catalysis can be highly dependent on the solvent within which the reaction is run.
In all of the attempted synthesis, a mixture of DMF, THF, and 0.5M HCl had been utilized in contrast to
literature reports which used DMSO instead of DMF. While the two are both polar aprotic solvents, side
by side reactions were run in order to detect any differences in the purity/efficiency. For ease, the Aloc
removal was performed on Fmoc-Lys(Aloc)-OH in solution phase.
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Scheme 3.7: Aloc deprotection efficiencies using DMSO or DMF

To simplify the comparison, the two reactions were run using equal amounts of each reagent for identical
durations. First, the protected amino acid was placed in a round bottom flask and placed under an inert N2
atmosphere. To the reaction flask was then added 5mL of a 2:2:1 solution of Solv:THF:0.5M HCl where
the solvent was either DMF or DMSO. It is noted that the Pd(0) catalyst precursor was significantly more
soluble in DMSO than in DMF initially. The solutions were then added via a syringe to the flasks and the
reactions were stirred for 24 hours. The reaction mixture was monitored via TLC with samples taken
every hour. Across the reaction time, as was found with previous Aloc removal studies, there was no
significant difference observed in the Rf values of the spots. After the allotted reaction time, the solvents
were evaporated from each sample and 1D 1H NMR’s of each were taken (Figure 3.9)

DMF

DMSO

Figure 3.9: Aloc deprotection of Fmoc-Lys(Aloc)-OH with different solvents

From the 1H NMR, both methods were shown to effectively remove the protecting Aloc groups. It is
noted that the conversion efficiency within this simple system was almost 25% more effective than that of
on-resin Aloc removal. It is therefore proposed that on-resin deprotection is slightly less effective
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possibly due to accessibility issues. Given the limited success on-resin, alternative methods of Aloc
deprotection were then investigated.
3.8 On-resin Aloc Deprotection of Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 with Dimedone42
After performing a literature search, an alternative method for Aloc removal utilizing dimedone as the
scavenger was found. This previously published method2 was then applied to the system at hand.

Scheme 3.8: On-resin cyclization of pentapeptide using Dimedone as scavenger

First, the pentapeptide was synthesized using SPPS as was accomplished earlier. Prior to catalyst
addition, the reaction vessel was purged with N2 and covered with aluminum foil to exclude light. To the
swollen resin, was then added 1 equivalent of tetrakistriphenylphosphinepalladium (0) (purified as
previously discussed) and 10 equivalents of dimedone in 2mL of a 1:1 solution of CH2Cl2:THF. The
solution was then agitated for 6 hours and subsequently washed with a 0.5% DIPEA/DMF (v/v) solution
and a 0.5% dimethyldithiocarbamic acid sodium salt solution in DMF (w/v) to remove any palladium
residues. Next, 1 equivalent of 1,1’-ferrocenedicarboxylic acid chloride and 10 equivalents of DIPEA in
10mL of DMF were added to the resin under N2. The reaction was agitated for 24 hours to allow for
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cyclization to occur. The resin was then treated with acetic anhydride in DMF to acylate any free amines
which still may be present. The peptide was subsequently cleaved from the resin, and the solvent
evaporated. The 1H NMR of the crude product (Figure 3.10) does not appear to contain peaks within the
ferrocene region (4.50ppm-5.00ppm) which integrate proportionally.

Figure 3.10: On resin cyclization of pentapeptide using dimedone as the scavenger

Based on the rough integrations, it was assumed that no appreciable quantity of the desired cyclized
product was synthesized and no purification attempts were made.
It is of note that the source for this methodology was the first to mention the necessity of washing the
resin with specific solutions post deprotection in order to remove any remaining palladium residues.
Neither of the previous literature papers provided such details. Upon deeper investigation, it was
discovered that all methodologies require special washes post deprotection. Given this, it is believed that
the lack of removal of Pd(0) in previous attempts may have interfered with the cyclization process. Pd(0)
is known to add to acid chorides, and as a result, excess catalyst may have been reacting with the 1,1’ferrocenedicarboxylic acid chloride during the subsequent step in synthesis.
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3.9 Solution Phase Cyclization of Ac-Lys(Z)-Ala-Val-Lys(Z)-Gly-NH2

Due to the unsuccessful on-resin cyclization, a solution phase variant was attempted using Z protected
lysine residues. First, the dried resin was added to the solid phase vessel and the resin was swelled with
CH2Cl2 for 30 minutes with agitation. The Fmoc protecting group was then removed via a series of
washes, followed by addition of the next amino acid dissolved in a minimal amount of DMF. The reaction
was then gently agitated by shaking for one hour. The resin was then washed and the Fmoc group was
once again removed, followed by subsequent addition of the next amino acid. This process could then be
repeated as many times as necessary to complete synthesis of the desired peptide. In this manner,
carboxybenzyl protected lysine, valine, alanine, and carboxybenzyl protected lysine were added to form
the desired pentapeptide Ac-Lys(Z)-Ala-Val-Lys(Z)-Gly-NH2. In order to remove the peptide from the
solid support, the resin was treated with a removal solution and agitated by shaking for 3 hours. After
rotary evaporation, the resulting peptide was triturated with diethyl ether to yield an off white solid.
1D 1H NMR indicated that the desired product was present with little to no impurities. To confirm the
peak assignments, a 2D 1H COSY was also taken and the exhibited cross peaks were consistent with the
initial assignments from 1D 1H NMR.
The product was then hydrogenated with 5% Pd on C under 40psi of H2 for 24 hours. The palladium
catalyst was then filtered off through celite and cyclization with ferrocene was attempted. To a stirring
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solution of the peptide under N2, 1 equivalent of 1,1’-ferrocenedicarboxylic acid chloride in 10mL of
DMF was added dropwise over an hour. The final concentration of 1,1’-ferrocenedicarboxylic acid
chloride in the solution was 0.75mM. The solution was allowed to stir for 24 hours and the solvent was
subsequently removed using a rotary evaporator. The 1H NMR of the product indicates that ferrocene is
present in the crude product mixture (Figure 3.11).

Figure 3.11: Solution Phase Cyclization of Ac-Lys-Ala-Val-Lys-Gly-NH2 with ferrocene

After evaporation the obtained black film was no longer soluble in MeOH. Due to time constraints, flash
chromatography could not be fully completed, although intial TLC analysis indicated that pure MeOH
was not a sufficient eluent. It is also noted that upon dissolution in DMF, the black film had a redish tint,
possibly indicative of the presence of ferrocene.
3.10 Summary and Conclusions
The pentapeptides Ac-Lys(Aloc)-Ala-Val-Lys(Aloc)-Gly-NH2 was successfully synthesized using
standard solid phase peptide synthesis techniques. While both solution and solid phase cyclization with
1,1’-ferrocenedicarboxylic acid chloride was attempted, neither yielded the desired products in any
recoverable quantity. Additionally, neither Aloc removal technique utilized for solution or solid phase
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synthesis was fully successful. As such, it is evident that an alternative technique must be utilized for
Aloc removal, or the current conditions must be refined for maximum efficiency.
In addition, the pentapeptide Ac-Lys(Z)-Ala-Val-Lys(Z)-Gly-NH2 was successfully synthesized. Based
on the 1H NMR spectrum, hydrogenation with 5% Pd on C under H2 only partially removed the Z
protecting groups. It is believed, however, that the catalyst loading and reaction time can be optimized to
ensure complete removal of the Z protecting groups. While full characterization of the product could not
be completed due to time constraints, the 1H NMR spectrum appears to indicate the presence of ferrocene
in the product. The best hypothesis based on the 1D 1H NMR integral values of the crude product, is that
the product is mostly comprised of a single ferrocene coupled to two pentapeptides.
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APPENDIX
A.1 Synthesis of Boc-Cys(SCH2CCH)-OH
Under an inert atmosphere of N2, 1.030g (0.044mol, 4.0 equiv) of sodium metal was dissolved in ~60mL
of absolute ethanol. Once fully dissolved, 1.956g (0.0111mol, 1.0 equiv.) of L-cysteine hydrochloride
hydrate and 4.90mL (0.044mol, 4.0 equiv.) of propargyl bromide was added to the solution and allowed
to react for 2 hours. The ethanol was then evaporated off using a rotary-evaporator and the remaining
product was redissolved in a minimal amount of THF. To the solution was then added 4.865g
(0.0223mol, 2.0 equiv.) of Boc2O that was previously dissolved in approximately 12.5mL of THF.
Additionally, 5.0mL (0.055mol, 5.0 equiv) of triethylamine and 25.0mL of deionized H2O was added to
the flask and allowed to stir covered overnight with a syringe inserted into the rubber septum for gas
change. The THF was then evaporated off and the solution was made basic through the addition of 1M
NaOH. The aqueous layer was then washed with 3× ~25mL of ethyl acetate, acidified to a pH of 2 using
concentrated HCl, and extracted using 3× ~25mL ethyl acetate. The remaining ethyl acetate layer was
dried using MgSO4 and filtered into a round bottom flask (tare mass: 99.647g) and evaporated off using
the rotary evaporator to yield a dark brown oil. The final mass of the flask was 101.606g (1.959g,
0.0133mol product). The product was then confirmed using 1H NMR and its purity was determined by
TLC (Figure A1). The product had an Rf value of 0.67 with an eluent of 1:1 ethyl acetate:methanol.

Figure A1: 1H NMR of Boc-Cys(Prg)-OH in CDCl3
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H NMR: (CDCl3) δ 6.356ppm (1H, bs, OH), 5.392ppm (1H, d, 3J=7.66 Hz, NH), 4.617ppm (1 H, q,

1

J=5.86, Cα-H), 3.3357ppm (2H, dd (qd), 2J=8.80Hz 3J=2.70Hz, CH2), 3.2687ppm (2 H, dd, 2J=13.27Hz

3
3

J=4.84, CH2), 2.3155ppm (1 H, s, alkyne), 1.498ppm (9H, s, Boc-CH3).

A.2 Synthesis of Boc-Cys(SCH2CCH)-Anisidine
0.500g (0.00193mol) of previously synthesized Boc-Cys(SCH2CCH)-OH was dissolved in 2.07mL of
CH2Cl2 to obtain a concentration of 0.9M. To the flask was then added 0.261g (0.00212mol, 1.1 equiv.)
anisidine and the solution was allowed to stir in an ice water bath. Once the solution had reached 0°C
(approximately 5 minutes) 0.443g (0.00231mol, 1.2 equiv.) of EDC was added and the solution was
allowed to slowly warm to room temperature over a 4 hour period. The CH2Cl2 was evaporated off using
a rotary evaporator and the remaining oil was redissolved in ethyl acetate and washed with 3×25mL of
0.1M HCl, 3×25mL of saturated NaHCO3 solution, and 1×25mL brine, after which the ethyl acetate layer
was dried with MgSO4 and the ethyl acetate was rotovapped off. The product was purified via flash
chromatography (3cm diameter column, 2:1ethyl acetate/hexanes eluent) and massed at 80.116g (tare:
79.858g). The structure was confirmed by 1H NMR and its purity was determined by TLC (Figure A2).
The product had an Rf value of 0.57 with an eluent of 2:1 hexanes:ethyl acetate. ESMS was also
performed on the given sample, and the molecular ion peak, in addition several fragments were confirmed
to be present.
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Figure A2: 1H NMR of Boc-Cys(Prg)-Anisidine in CDCl3

H NMR: (CDCl3) δ 8.1661ppm (1H, s, Ani-NH), 7.4289ppm (2 H, d, 3J=8.93Hz, Ani-CH), 6.8674ppm

1

(2H, d, 3J=9.05, Ani-CH), 5.4372 (1H, d, 3J=6.64Hz, Cys-NH), 4.4887ppm (1 H, q, 1J=6.76, CαH),
3.7954ppm (3H, s, OMe), 3.343ppm (2 H, d, 3J=2.60, Prg-CH2), 3.1499ppm (2H, s (qd), 2J=52.21Hz,
3

J=14.02Hz, Cys-CH2), 2.3223ppm, 1H, s, Alkyne-H), 1.4785ppm, 9H, s, Boc-(CH3)3).

A.3 Synthesis of Boc-Cys(SCH2CCH)-OSu
0.500g (0.00193mol) of Boc-Cys(SCH2CCH)-OH was dissolved in 4.00mL of CH2Cl2 and to this solution
was added 1.56g (0.0145mol, 7.5 equiv.) of N-hydroxysuccinimide. The solution was then placed in an
ice bath and allowed to cool to 0°C. Once at the desired temperature, 0.444g (0.00232mol, 1.2 equiv.) of
EDC was added to the flask and the reaction was left for 4 hours while the solution slowly warmed to
room temperature. An additional 15mL of CH2Cl2 was then added to the reaction flask and the solution
was washed with 3× 25mL of 0.1HCl, 3×25mL of saturated NaHCO3 solution, and 1× 25mL brine. The
CH2Cl2 layer was then dried using MgSO4, filtered, and evaporated using a rotary evaporator. The crude
product was then purified using flash chromatography (3cm diameter column, 7:3 hexanes/ethyl acetate
(350mL) and pure ethyl acetate eluents). The product was then massed at 45.198g (tare: 45.086g) and its
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structure was confirmed by 1H NMR and its purity was determined by TLC (Figure A3). The desired
product had an Rf value of 0.65 with an eluent of 2:1 ethyl acetate:hexanes.

Figure A3: 1H NMR of Boc-Cys(Prg)-OSu in CDCl3

H NMR: (CDCl3) δ 5.396ppm (1H, d, 3J=8.74Hz, Cys-NH), 4.9367ppm (1H, q, 2J=5.46Hz, 3J=6.92Hz,

1

CαH), 3.3824ppm (2H, d, 3J=2.37Hz, Prg-CH2), 3.2248ppm (2H, s (qd), 2J=40.17 Hz, 14.40Hz, 3J=7.48,
Cys-CH2), 2.8634ppm (4H, s, OSu), 2.3214ppm (1H, s, Alkyne-H), 1.4663ppm (9 H, s, Boc CH3)3).

A.4 Synthesis of CF3CO2[Cys(SCH2CCH)-Anisidine]
0.100g(0.000274mol) of Boc-Cys(SCH2CCH)-Anisidine was dissolved in ~1ml of CH2Cl2 and a single
drop of anisole was added to the stirring solution. The reaction flask was placed in an ice bath and
allowed to cool to 0°C. Once at the target temperature, 1mL of TFA was additionally added to the
solution. The flask was slowly warmed to room temperature by the ambient room temperature (~45hours) and the CH2Cl2 and TFA were stripped off using a high vacuum rotary evaporator. The greyyellow colored oil was left on the vacuum line overnight and massed the next day 37.832g (tare:
37.709g).
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A.5 Synthesis of Boc-Cys(SCH2CCH)-Cys(SCH2CCH)-Anisidine
0.0726g(0.000274mol) of CF3CO2[Cys(SCH2CCH)-Anisidine] was first dissolved in a minimal amount
of CH2Cl2 and a stir bar was added to the flask. To the stirring solution were then added 0.98g(1 equiv.)
of Boc-Cys(SCH2CCH)-OSu and 0.29mL(7.6 equiv) of triethylamine in quick succession. The solution
was allowed to react for 4 hours at room temperature and the CH2Cl2 was stripped off using a rotary
evaporator. The golden yellow brown residue was then redissolved in ethyl acetate and transferred to a
separatory funnel. The solution was washed with three times with 10mL of 0.1M HCl, three times with
10mL of saturated NaHCO3 solution, and once with 10mL of brine. The ethyl acetate layer was then
transferred into a round bottom flask and the ethyl acetate was stripped from the solution and the flask
was massed at 55.672g (tare: 55.630g), yielding a product mass of 0.042g. The product was then
confirmed by both TLC and 1H NMR (Figure A4). The product was shown to be pure by TLC with an Rf
of 0.60 in 3:2 ethyl acetate:hexanes. ESMS was also performed on the given sample, and the molecular
ion peak, in addition several fragments were confirmed to be present.

Figure A4: 1H NMR of Boc-Cys(Prg)-Anisidine in CDCl3

58
H NMR: (CDCl3) δ 8.707ppm (1H, s, Ani-NH), 7.4502ppm (2H, d, 2J=35.1Hz, 3J=9.13, Ani-CH),

1

6.1893ppm (2H, d, 3J=9.02Hz, Ani-H), 5.6185ppm (1H, d, 3J=6.37, Cys-NH), 5.523ppm (1H, d,
2

J=99.54Hz, 3J=7.64, Cys-NH), 4.8748ppm (1H, q, 2J=5.94, 2J=5.94, Cα), 4.4526ppm (1H, q, 2J=5.94,

2

J=5.94, Cα), 3.7697ppm (3H, s, OMe), 3.306ppm (4H, m, Cys-CH2), 3.119ppm (4H, m, Cys-CH2),

2.332ppm (2H, m, Alkyne-H), 1.4418ppm (1H, s, Boc-(CH3)3).

A.6 Synthesis of W(dmtc)2(Boc-Cys(SCH2CCH)-Cys(SCH2CCH)-Anisidine)
Approximately 1500mL of methanol was first degassed using a partial vacuum and filtration flask. In the
hood a 2L 3-neck Schlenk flask was set up within which 0.504g of W(dmtc)2(CO)3, which had been
previously synthesized, was transferred. About 1.1L of the degassed methanol was then added to the 3neck reaction flask in addition to a stir bar. The stirring solution was then put under an inert atmosphere
of N2 and stirred until most of the solid had dissolved. The solution was then brought to a gentle reflux
using a heating mantle. Once at the moderate reflux, 0.504g of Boc-Cys(SCH2CCH)-Cys(SCH2CCH)Anisidine, which had been dissolved in a 7mL of the degassed methanol, was added to the stirring
solution using a 10mL syringe. Upon addition of the peptide, the solution immediately became a dark
forest green color, indicating formation of the mono-alkyne complex. Reflux of the solution was
continued until the solution had become a lemon yellow color, indicating that both alkynes had been
coordinated, which took approximately 45 minutes to accomplish. The methanol was then stripped from
solution. The product was then purified using flash chromatography and an eluent of 1:1 ethyl
acetate:hexanes. Fractions 115-140 were then combined and transferred to a round bottom flask which
was massed at 63.329g (tare: 62.291g), yielding a product mass of 0.408g. The desired product was then
confirmed via 1H NMR, TLC, and ESI-MS (Figure A5, Figure A7). The desired product had an Rf value
of 0.20 with an eluent of 1:1 ethyl acetate:hexanes. The purity of the product was also tested using HPLC
(Figure A6). For HPLC analysis the gradient is provided in Table A1. Absorbance readings were all
recorded at 310nm.
Table A1: HPLC Gradient programming for Purity Analysis of W(dmtc)2(Boc-Cys(Prg)-Cys(Prg)-Ani
Time

0.1% TFA

Acetonitrile

Flow

0

80

20

1 ml/min

6

50

50

1

12

0

100

1

20

0

100

1

22

80

20

1

59

Figure A5: 1H NMR of W(dmtc)2(Boc-Cys(Prg)-Cys(Prg)-Ani)in CDCl3

H NMR: (CDCl3) δ 11.3ppm (2H, s (m), Alkyne-H), 8.707ppm (1H, s, Ani-NH), 8.529ppm (1H, s, Gly-

1

NH), 7.5935ppm (2H, m, Ani-CH), 6.8515ppm (2H, m, Ani-CH), 5.324ppm (1H, m, Gly-NH),
3.7997ppm (3H, m, OMe), 3.3137ppm (10H, m, DMTC + CH2), 3.127ppm (10H, m, DMTC + CH2),
1.461ppm (9H, m, Boc-(CH3)3).
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Figure A6: HPLC analysis of W(dmtc)2(Boc-Cys(Prg)-Cys(Prg)-Ani)
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Figure A7: ESI-MS of W(dmtc)2(Boc-Cys(Prg)-Cys(Prg)-Ani) with theoretical mass and isotope pattern

A.7 Variable Temperature studies of W(dmtc)2(Boc-Cys(SCH2CCH)-Cys(SCH2CCH)-Anisidine)
A series of 1D 1H NMR spectrums with increasing sample temperatures was recorded. First, in order to
avoid solvent evaporation effects during the heating process, the sample was dissolved in DMSO-d6.
Next, an initial NMR was recorded at 293K, the normal temperature of the instrument. The probe was
then heated to 300K and a second 1H NMR was recorded. 1D 1H NMR’s were then taken at 320K, 330K,
340K, 350K, 360K, and 364K, the maximum achievable temperature of the instrument. The sample was
then allowed to cool down to its normal temperature (293K) and a final 1H NMR spectrum was recorded
(Figure A8).
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Figure A8: Vartaible Temperature 1H NMR of W(dmtc)2(Boc-Cys(Prg)-Cys(Prg)-Ani)in DMSO-d6

The results of the VT-1H-NMR show near coalescence of the sample at 363K.

A.8 DMSO titration of W(dmtc)2(Boc-Cys(SCH2CCH)-Cys(SCH2CCH)-Anisidine)
In addition, a DMSO titration was performed in which 10mg of sample was dissolved in 75μL of CH2Cl2
and the concentration of DMSO in the sample was increased in specific intervals. First, a 1H NMR was
recorded in pure CDCl3. Next, 8µL of DMSO-d6 was added to the sample and a 1H NMR was recorded.
This was repeated 3 more times. This process was then repeated for two 16µL DMSO-d6 additions, one
32µL addition and three 50μL additions. The chemical shifts of the two amide protons within the
compound were then recorded for each of the 1H NMR spectrums taken (Figure A9, Table A2). The
chemical shift was then plotted as a function of the DMSO-d6 concentration in the sample. When graphed
the results of the DMSO titration clearly indicate that both amide protons in the coordinated peptide are
involved in hydrogen bonds.
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Figure A9: Chemical shift of selected NH peaks as a function of %DMSO of solvent
Table A2: DMSO Titration data
Solvent % DMSO

Location of 1st NH peak

Location of 2nd NH peak

0

8.493

8.873

0.096386

8.565

9.118

0.175824

8.632

9.312

0.242424

8.701

9.448

0.299065

8.771

9.541

0.390244

8.844

9.612

0.460432

8.941

9.679

0.571429

9.035

9.735

0.666667

9.131

9.784

0.727273

9.209

9.82

0.769231

9.254

9.84
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A.9 Synthesis of W(dmtc)2(Boc-Prg-Prg-OMe)
A sample of Boc-Prg-Prg-OMe was first obtained from previous research and the structure of the sample
was confirmed using 1H NMR (Figure A10).

Figure A10: 1H NMR of Boc-Gly(Prg)-Gly(Prg)-OMe in CDCl3

H NMR: (CDCl3) δ 7.169ppm (1H, s, Boc-Gly-NH), 5.386ppm (1H, s, Gly-NH), 4.673ppm (1H, s, Gly-

1

Cα), 4.311ppm (1H, s, Gly-Cα), 3.7234ppm (3H, s, OMe), 2.7144pp,-2.5665ppm (4H, s, Gly-Prg CH2),
2.0523ppm (1H, s, Alkyne), 1.983ppm (1H, s, Alkyne), 1.3999 (9H, s, Boc-CH3)
0.0915g (1 equiv) of the sample was then placed within a 3 neck 500mL round bottom flask, while
300mL of methanol was degassed using a partial vacuum and a filter flask. Approximately 200mL of the
degassed methanol and a stir bar were then transferred to the reaction vessel and the solution was put
under an inert atmosphere of N2. The solution was then heated to a moderate reflux until most of the solid
had dissolved. 0.055g (0.180mmol) of the Boc-Prg-Prg-OMe was then dissolved in a minimal amount of
methanol and added into the stirring solution using a syringe. Upon addition of the peptide, the solution
immediately became a dark forest green color, indicating formation of the mono-alkyne complex. Reflux
of the solution was continued until the solution had become a lemon yellow color, indicating that both
alkynes had been coordinated, which took approximately 2 hours to accomplish. The methanol was then
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stripped from solution using a high vacuum rotary evaporator and the flask was massed at 131.260g (tare:
131.121). The product was then redissolved in methylene chloride and methanol and flash
chromatography was performed using a 2cm column and ethyl acetate as the eluent. Fractions 9-12 were
pooled and confirmed to be the desired product through 1H NMR (Figure A11). The flask was massed at
64.633g (tare: 64.553g). In addition a variable temperature NMR was conducted starting at 294K and
increased at intervals of 10K to 344K, but no evidence of coalescence was noted.

Figure A11: 1H NMR of W(dmtc)2Boc-Gly(Prg)-Gly(Prg)-OMe in CDCl3
H NMR: (CDCl3) δ 11.302ppm (2H, m, Alkyne-H), 5.369ppm (1H, s (d), 3J= 3.64Hz, Gly-NH),

1

4.871ppm (1H, d, 3J=3.64Hz, Gly-NH), 4.55ppm (1H, s (q), Gly-Cα), 4.27ppm (1H, s (q), Gly-Cα),
3.753ppm (3H, d (s), 3J=4.48Hz, OMe), 3.4017ppm (6H, s (dq), 2J=10.55, 3J=4.16Hz, dmtc), 3.0993ppm
(6H, s (dq), 2J=10.55, 3J=6.80, dmtc), 1.3842ppm (9H, s, Boc-(CH3)3).

A.10 Variable Temperature studies of W(dmtc)2Boc-Gly(Prg)-Gly(Prg)-OMe
A series of 1D 1H NMR spectrums with increasing sample temperatures was recorded. First, in order to
avoid solvent evaporation effects during sample heating, the compound was dissolved in DMSO-d6. Next,
an initial NMR was recorded at 293K, the normal temperature of the instrument. The probe was then
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heated to 303K and a second 1H NMR was recorded. 1D 1H NMR spectrums were then taken at 313K,
323K, 333K, and 343K. The sample was then allowed to cool down to its normal temperature (293K) and
a final 1H NMR spectrum was recorded (Figure A12).

293K
343K
333K
323K
313K
303K
293K

Figure A12: Variable Temperature studies of W(dmtc)2Boc-Gly(Prg)-Gly(Prg)-OMe in DMSO-d6
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